Author:
Cantu David,Pereira Ana,Hall Diane,Grinnell Todd
Subject
Neurology (clinical),Neurology
Reference8 articles.
1. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy;Ben-Menachem;Epilepsy Res.,2010
2. BIAL - Portela & Ca, S.A., 2019. Zebinix [Summary Of Product Characteristics]. BIAL - Portela & Ca, S.A., PT-4745–457 S. Mamede do Coronado, Portugal.
3. Adjunctive eslicarbazepine acetate: a pooled analysis of three phase III trials;Biton;Epilepsy Behav.,2017
4. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study;Elger;Epilepsia,2009
5. Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment;Klein;Epilepsia,2017